2013 Fiscal Year Final Research Report
Development of the molecular imaging and the therapy of the unstable plaque targeting activated macrophages
Project/Area Number |
23591105
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Circulatory organs internal medicine
|
Research Institution | Kagoshima University |
Principal Investigator |
MIYATA MASAAKI 鹿児島大学, 医歯(薬)学総合研究科, 准教授 (00347113)
|
Co-Investigator(Kenkyū-buntansha) |
MATSUYAMA Takami 鹿児島大学, 医歯学総合研究科, 教授 (30145479)
|
Co-Investigator(Renkei-kenkyūsha) |
FURUSHO Yuko 鹿児島大学, 医歯学総合研究科, 助教 (00632514)
|
Project Period (FY) |
2011 – 2013
|
Keywords | 動脈硬化 / 葉酸レセプターβ / マクロファージ |
Research Abstract |
The folic acid receptor beta (FR-beta) attracts attention as a marker of activated macrophages. We found that the activated macrophage which expressed FR-beta was present in the arteriosclerosis lesion of the arteriosclerosis model mouse. We administrated the recombinant immunotoxin which coupled Pseudomonas aeruginosa toxin to anti-FR-beta monoclonal antibody into the arteriosclerosis model mice, selectively killed the activated macrophages, and demonstrated that it reduced arteriosclerotic lesion. In addition, we established a sandwich ELISA assay using anti-FR-beta monoclonal antibody and measured the soluble FR-beta concentration of human serum. The patients with aortic aneurysms showed a higher serum FR-beta level compared with the normal control. The measurement of the soluble FR-beta concentration is suggested to be useful for the diagnosis of atherosclerosis.
|
Research Products
(9 results)
-
[Journal Article] Novel therapy for atherosclerosis using recombinant immunotoxin against folate receptorβ-expressing macrophages2012
Author(s)
Furusho Y, Miyata M, Matsuyama T, Nagai T, Li H, Akasaki Y, Hamada N, Miyauchi T, Ikeda Y, Shirasawa T, Ide K, Tei C
-
Journal Title
J Am Heart Assoc
Volume: 1
Pages: e003079
DOI
Peer Reviewed
-
-
-
-
-
-
-
-